Biopharmaceutical Analysis & Statistics, July 2013 (p20)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: protein, biomedical, antibody, more »

571-600 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Competitor Analysis ErbB / Her Receptor Antagonists

Competitor Analysis ErbB / Her Receptor Antagonists

  • $ 858
  • Industry report
  • July 2013
  • by La Merie Publishing

Competitor Analysis ErbB / Her Receptor Antagonists Product description The present Competitive Intelligence Report about antagonists of the ErbB/Her receptor pathway provides a competitor evaluation ...

  • Industries : Biopharmaceutical
Biopharmaceuticals - A Global Market Overview

Biopharmaceuticals - A Global Market Overview

  • $ 4 500
  • Industry report
  • July 2013
  • by Industry Experts

`The pharmaceutical R&D pipeline and industry have been witnessing greater degree of dependence on biopharmaceuticals. Development of these products is being undertaken by a growing number of players in ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Sports Nutrition in Pakistan

Sports Nutrition in Pakistan

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Despite having a young population and increased awareness, Pakistan continues to experience an overall low health consciousness as consumers across most income groups are concerned with feeding their families ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Pakistan
Sports Nutrition Market Overview in Estonia

Sports Nutrition Market Overview in Estonia

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Sports nutrition in Estonia declined by nearly 5% as value sales accounted for EEK720,000 in 2010. As many people ended their memberships at various sports clubs, the sales of sports nutrition in Estonia ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Estonia
Sports Nutrition Market Analysis in Nigeria

Sports Nutrition Market Analysis in Nigeria

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

And with an improved economy in 2010 compared to the previous year, the category saw a growth rate of 11% in current value terms. This is slower than the review period average, due to the fact that the ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Nigeria
Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023

Biosimilar Monoclonal Antibodies: World Market Prospects 2013-2023

  • $ 2 846
  • Industry report
  • July 2013
  • by Visiongain

Report Details Biosimilar monoclonal antibodies - this new study shows you potential sales What does the future hold for biosimilar therapeutic antibodies? Visiongain's new report predicts revenues to ...

  • Industries : Biopharmaceutical
  • Countries : World
The Global Food and Beverage Processing Enzyme Market 2013 2018: Trends, Forecast, and Opportunity Analysis, July 2013

The Global Food and Beverage Processing Enzyme Market 2013 2018: Trends, Forecast, and Opportunity Analysis, July 2013

  • $ 3 900
  • Industry report
  • July 2013
  • by Lucintel

Background: The worldwide enzyme market for food and beverage industry is expected to reach $1.69 billion by 2018, with a moderate growth over the next five years. The use of enzyme is growing in food ...

  • Industries : Biopharmaceutical
  • Countries : World
Sports Nutrition in Georgia

Sports Nutrition in Georgia

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

The awareness of sports nutrition and the consuming culture of the category are rather low in Georgia. It was first introduced in Georgia only in 2011, with Trec Nutrition as the pioneer company. Before ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Georgia
Antibody Target, Technology & Pipeline Database: 1-year Subscription

Antibody Target, Technology & Pipeline Database: 1-year Subscription

  • $ 1 716
  • Industry report
  • July 2013
  • by La Merie Publishing

Antibody Target, Technology & Pipeline Database: 1-Year Subscription Product description Subscription to La Merie Publishing's proprietary Antibody Database provides online access to information about ...

  • Industries : Biopharmaceutical
Zenotech Laboratories Limited (Symbol:532039) SWOT Analysis, Strategy, Revenues and Profits

Zenotech Laboratories Limited (Symbol:532039) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Sports Nutrition Market Analysis in Italy

Sports Nutrition Market Analysis in Italy

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Anecdotal evidence, as well as fitness market sources, indicate that a rising number of people have a fitness club membership. This trend is further supported by vanity and health concerns among younge ...

  • Industries : Sport Nutritional, Biopharmaceutical
  • Countries : Italy
Physician Views: Biosimilar Remicade poised for approval in Europe - are rheumatologists and gastroenterologists ready?

Physician Views: Biosimilar Remicade poised for approval in Europe - are rheumatologists and gastroenterologists ready?

  • $ 645
  • Industry report
  • July 2013
  • by Firstword Pharma

Scope of the Report The recent recommendation to approve a biosimilar version of Merck & Co./Johnson & Johnson's Remicade in Europe has gone a long way to validate the regulatory pathway for biosimila ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Charting the Biosimilar and Biobetter Development Pipeline (2013)

Charting the Biosimilar and Biobetter Development Pipeline (2013)

  • $ 1 950
  • Industry report
  • July 2013
  • by Firstword Pharma

If you need to understand the important biosimilar and biobetter drug developments worldwide then this report is critical. The promise of biosimilars has been great but beyond the first wave of products ...

  • Industries : Biopharmaceutical
  • Countries : United States, World
Enzymes Markets in China

Enzymes Markets in China

  • $ 4 000
  • Industry report
  • July 2013
  • by Asia Market Information & Development Company

China's demand for enzymes has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment ...

  • Industries : Biopharmaceutical
  • Countries : China
STRATEC Biomedical Systems AG (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

STRATEC Biomedical Systems AG (Symbol:SBS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2013

Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • June 2013
  • by Global Markets Direct

Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Alder Biopharmaceuticals Inc. - Product Pipeline Review - 2013? provides data on ...

  • Industries : Biopharmaceutical
  • Countries : World
Bleeding And Clotting Disorders - Pipeline Review, H1 2013

Bleeding And Clotting Disorders - Pipeline Review, H1 2013

  • $ 2 000
  • Company report
  • June 2013
  • by Global Markets Direct

Bleeding And Clotting Disorders - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Bleeding And Clotting Disorders - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic ...

  • Industries : Biopharmaceutical
  • Countries : China
Kerecis ehf - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kerecis ehf - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • June 2013
  • by Global Data

Summary Kerecis ehf is a medical device company engaged in the development of novel tissue-regeneration technologies based on proprietary fish-derived protein technologies that can be used in reconstructive, ...

  • Industries : Biopharmaceutical
Food Enzymes Market By Types (Carbohydrase, Protease, Lipase), Applications (Beverages, Dairy, Bakery), Sources (Microorganisms, Plants, Animals) & Geography - Global Trends & Forecasts To 2018

Food Enzymes Market By Types (Carbohydrase, Protease, Lipase), Applications (Beverages, Dairy, Bakery), Sources (Microorganisms, Plants, Animals) & Geography - Global Trends & Forecasts To 2018

  • $ 4 650
  • Industry report
  • June 2013
  • by MarketsandMarkets

Food enzymes act as highly selective catalyst and function in the metabolic reactions and in the inter conversion of complex molecules to smaller ones. Enzymes form an integral part of the global food ...

  • Industries : Biopharmaceutical
  • Countries : World
Omrix Biopharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

Omrix Biopharmaceuticals, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Israel
Triple Analysis: Melanoma, Cancer Vaccines and Antibodies

Triple Analysis: Melanoma, Cancer Vaccines and Antibodies

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Cancer Vaccines) and one compound specific area (Antibodies). ...

  • Industries : Biopharmaceutical
Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies

Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies

  • $ 5 175
  • Industry report
  • June 2013
  • by Bioseeker

This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Melanoma), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area ...

  • Industries : Biopharmaceutical
BioExx Specialty Proteins, Ltd. (Formerly, Bio-Extraction, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioExx Specialty Proteins, Ltd. (Formerly, Bio-Extraction, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical, Sport Nutritional
Transposagen Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Transposagen Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Protein Sciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Protein Sciences Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Ondine Biomedical, Inc. (formerly Ondine Biopharma Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Ondine Biomedical, Inc. (formerly Ondine Biopharma Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Chronix Biomedical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Chronix Biomedical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Keryx Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Keryx Biopharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
XTL Biopharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

XTL Biopharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
Nabi Biopharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Nabi Biopharmaceuticals - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biopharmaceutical
About 3 200 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Industry - Company Report, October 2014

  • Department of Health and Human Services
  • October 2014
    12 pages
  • Vaccine  

  • Africa  

    United States  

    Uganda  

View report >

Global Vaccine Industry

September 2014

Vaccine Market In The Us

September 2014

27 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Merck KGaA

Germany

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.